Trademark Overview
On Monday, May 12, 2025, a trademark application was filed for CGT NAVIGATE with the United States Patent and Trademark Office. The USPTO has given the CGT NAVIGATE trademark a serial number of 99180209. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, December 9, 2025. This trademark is owned by Emerging Therapy Solutions, Inc.. The CGT NAVIGATE trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Business management and consulting services for the health care industry, namely, business management of cell, gene, transplant, and other complex medical therapies for health plans, health insurers, self-funded plans, and reinsurers; Business management and administration in the field of healthcare, namely, development, creation and implementation of health care provider networks in the field of cell, gene, transplant, and other complex medical therapies; Business administration of cell, gene, transplant, and other complex medical therapy programs; Business research in the field of health care relating to cell, gene, transplant, and other complex medical therapy programs; Medical cost management relating to cell, gene, transplant, and other complex medical therapies.
Consulting services in the field of medical care, namely, developing medical treatment policies related to cell, gene, transplant, and other complex medical therapies; Providing information in the field of health care, namely, models of care, medical practice, and health care delivery and outcomes, all relating to cell, gene, transplant, and other complex medical therapies
Preferred provider network programs, namely, administration of medical services in the nature of cell and gene therapies, solid organ and bone marrow transplants and other complex medical therapies provided through a network of health care providers; Preferred provider network services, namely, administering medical benefits in the nature of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies provided through a network of health care providers under an insurance plan
